A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
Clinical trial NCT02403310 · COMPLETED
Trial details
- NCT number
- NCT02403310
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-18
- Primary completion
- 2016-09-13
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.